Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2004-12-21
2009-06-30
Allen, Marianne P (Department: 1647)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C514S012200, C514S04400A, C424S130100
Reexamination Certificate
active
07553496
ABSTRACT:
The invention relates to methods and compositions for the treatment or prevention of ocular angiogenesis and neovascularization associated with neovascular disease. Administration of vascular endothelial growth factor (VEGF)-A into the eye when macrophage infiltration is reduced inhibits ocular angiogenesis.
REFERENCES:
patent: 6177401 (2001-01-01), Ullrich et al.
patent: 6397849 (2002-06-01), Bowman et al.
patent: 6524799 (2003-02-01), Walker et al.
patent: 7335371 (2008-02-01), Sackeyfio et al.
patent: 2002/0151680 (2002-10-01), Alitalo et al.
patent: 2003/0118579 (2003-06-01), Walker et al.
patent: 2004/0110757 (2004-06-01), Arrhenius et al.
patent: 2005/0176669 (2005-08-01), Al-Murrani
Kupprion et al., Journal of Biological Chemistry, 273(45):29635-29640, 1998.
Shih, S. et al.,Selective stimulation of VEGER-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. (2003) J Clinical Invest 112, 50-57.
Carmeliet, P. et al.Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. (2001) Nat Med 7, 575-83.
Hiratsuka, S. et al.Involvement of flt-1 tyrosine kinase(vascular endothelial growth factor receptor-1)in pathological angiogenesis. (2001) Cancer Res 61, 1207-1213.
Bussolati, B. et al.Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. (2001) Am J Pathol 159, 993-1008.
Lopez, P. F., et al.,Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. (1996) Invest Ophthalmol Vis Sci 37, 855-68.
Saishin, Y. et al.VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. (2003) J Cell Physiol 195, 241-8. These data are the bases for current clinical trials of anti-VEGF-A therapy in patients with AMD.
Spilsbury, K., et al.,Overexpression of vascular endothelial growth factor(VEGF)in the retinal pigment epithelium leads to the development of choroidal neovascularization. (2000) Am J Pathol 157, 135-44.
Schwesinger, C. et al.Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. (2001) Am J Pathol 158, 1161-1172.
Oshima, Y. et al.Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol Published Online: Jun. 7, 2004, DOI: 10.1002/jcp.20110 (2004).
Schmidt-Erfurth, U. et al.Influence of photodynamic therapy on expression of vascular endothelial growth factor(VEGF),VEGF receptor 3, and pigment epithelium-derived factor. (2003)Invest. Ophthalmol. Vis. Sci. 44, 4473-4480.
Grossniklaus, H. E. et al. Macrophage and retinal pigment epithelium expression of anglogenic cytokines in choroidal neovascularization. (2002)Mol Vis8, 119-26.
Sakurai, E. et al.Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. (2003) Invest Ophthalmol Vis Sci 44, 2743-9.
Sakurai, E., et al.,Macrophage depletion inhibits experimental choroidal neovascularization. (2003) Invest Ophthalmol Vis Sci 44, 3578-85.
Allen Marianne P
McDermott Will & Emery LLP
University of Kentucky Research Foundation
LandOfFree
VEGF-A as an inhibitor of angiogenesis and methods of using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VEGF-A as an inhibitor of angiogenesis and methods of using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VEGF-A as an inhibitor of angiogenesis and methods of using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4126676